The personal burden for caregivers of children with phenylketonuria: A cross-sectional study investigating time burden and costs in the UK.
BACKGROUND
Management of phenylketonuria (PKU) is mainly achieved through strict dietary control that aims to limit the intake of phenylalanine (Phe). Adherence to this diet is burdensome due to the need for specially prepared low-Phe meals and regular monitoring of Phe concentrations. A UK cross-sectional study was conducted to identify the personal time and monetary burden associated with aspects of the PKU lifestyle for caregivers of children (aged < 18 years) living with PKU.


METHODS
Caregivers of pediatric patients with PKU attending one of four specialist metabolic centers in the UK were invited to participate in a questionnaire-based survey that evaluated different aspects of PKU management that could potentially present out-of-pocket costs (OOPCs) or time burden. Medical clinicians/dieticians provided patient information on PKU severity and an assessment of blood Phe control.


RESULTS
The survey was completed by 114 caregivers of 106 children having mild or moderate (n = 45; 39%) or classical (n = 60; 53%) PKU (severity data missing for n = 1), among whom 8 (8%) and 87 (82%) reported poorly controlled and controlled blood Phe status, respectively; Phe control data were missing for 11 children. Dietary management of PKU incurred a median time burden of > 19 h per week. OOPCs were incurred via attendance at PKU events, PKU-related equipment, and extra holiday expenditure. 21% of caregivers reduced their working hours (median 18.5 h/week) to care for their child, with a further 24% leaving their paid jobs completely.


CONCLUSIONS
Dietary management of PKU is associated with a considerable time burden for caregivers of pediatric patients with PKU. A personal financial burden also arises from OOPCs and lost earnings.
Dietetic Department, The Children's Hospital, Birmingham, B4 6NH, UK.
Anita
A
MacDonald
Mapi Ltd, London, N1 9BE, UK.
T Alexander
TA
Smith
Mapi Ltd, London, N1 9BE, UK.
Shamika
S
de Silva
EMD Serono Inc., Rockland, MA, USA.
Veronica
V
Alam
Mapi Ltd, 3995 AX Houten, The Netherlands.
Jeanni M T
JM
van Loon
ACBS, Advisory Committee on Borderline Substances; Burden; Caregiver; DLA, Disability Living Allowance; Diet; NHS, National Health Service; NRES, NHS Research Ethics Committees; OOPC, out-of-pocket cost; PAH, phenylalanine hydroxylase; PKU, phenylketonuria; Pediatric; Phe, phenylalanine; Phenylalanine; Phenylketonuria